Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States

The rapid development of commercially available molecular assays in response to the COVID-19 pandemic has been essential in identifying positive cases and guiding state and national response plans. With over 200 SARS-CoV-2 molecular tests having received emergency use authorization by the US Food an...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Michelle R., Binnicker, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858713/
https://www.ncbi.nlm.nih.gov/pubmed/35636818
http://dx.doi.org/10.1016/j.cll.2022.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858713/
https://www.ncbi.nlm.nih.gov/pubmed/35636818
http://dx.doi.org/10.1016/j.cll.2022.02.001

Ejemplares similares